Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

First Approval For AZ's Roxadustat With China Green Light

Dec 18 2018

• By Kevin Grogan

The Terracotta Army — China blazing a trail with roxadustat approval • Source: Shutterstock

Related Content

Phase III Roxadustat ALPS Data Positive For New Class Of Anemia Therapies

Sep 20 2018

AstraZeneca’s Lokelma Approved In US With Label Benefits Over Veltassa

May 21 2018

Related Companies

AstraZeneca PLC

FibroGen, Inc.

Amgen, Inc.

Pfizer Inc.

Astellas Pharma, Inc.

Akebia Therapeutics, Inc.

GSK plc

Kyowa Kirin Co., Ltd.

Additional Topics

China Asia Pacific International Approvals Renal BioPharmaceutical

More from Genitourinary

More from Therapeutic Category

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.